Regression patterns of choroidal melanoma: After palladium-103 (103Pd) plaque brachytherapy

被引:12
作者
Maheshwari, Abhilasha [1 ]
Finger, Paul T. [1 ]
机构
[1] New York Eye Canc Ctr, 115 East 61st St,Suite 5B, New York, NY 10065 USA
关键词
Choroidal melanoma; regression; pigment; exudative; ultrasound; FACTOR BEVACIZUMAB AVASTIN; POSTERIOR UVEAL MELANOMA; PROTON-BEAM IRRADIATION; RADIATION-THERAPY; TUMOR-REGRESSION; RU-106; BRACHYTHERAPY; GAMMA-KNIFE; RADIOTHERAPY; RETINOPATHY; OUTCOMES;
D O I
10.1177/1120672118776146
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To describe the patterns of regression of choroidal melanoma after treatment with plaque brachytherapy. Methods: Retrospective interventional case series including 170 consecutive patients treated with Pd-103 eye plaque radiation for choroidal melanoma. Outcome measures were changes in tumor thickness, surface characteristics, tumor vascularity, ultrasonography, fluorescein angiography, optical coherence tomography, and histopathology. Results: The mean initial tumor thickness was 3.9 mm (median 2.8 mm; range 2-11.3 mm) that decreased to 1.7 mm (median 1.2 mm; range 0-7.1 mm) after plaque brachytherapy. On imaging, tumors were pigmented in 51% (n = 86/170), amelanotic in 10% (n = 17/170), and variably pigmented in 39% (n = 67/170). Tumor pigmentation increased in 64% (n = 106/166), decreased in 18% (n = 30/166), and was unchanged in 18% (n = 30/166). Of the 120 that demonstrated intrinsic vascularity, 10% (n = 12/120) had decreased tumor-related vascularity and 90% (n = 108/120) showed complete resolution. Subretinal fluid was present in 34% (n = 58/170) of eyes at presentation. Of them, 15% (9; n = 9/58) had persistent SRF at last follow-up. On ultrasound imaging, 88% (n = 149/170) tumors presented with low to moderate internal reflectivity of which 61% (n = 91/149) showed increased reflectivity on regression. We noted a crescendo-decrescendo fluctuation in the presence of orange pigment lipofuscin along with complete resolution of drusenoid retinal pigment epithelial detachments. In the entire series of 170 patients, there was 0.5% (1) failure of local control, 2% (4) secondary enucleations, and 6% (10) patients developing metastasis. Conclusion: Findings related to choroidal melanoma regression after Pd-103 plaque brachytherapy included decreased intrinsic tumor vascularity, decreased tumor-related subretinal fluid, increased pigmentation, specific changes in orange pigment lipofuscin and resolution of drusenoid retinal pigment epithelial detachments, as well as decreased tumor thickness with an increase in internal reflectivity on ultrasound.
引用
收藏
页码:722 / 730
页数:9
相关论文
共 46 条
[1]   CHANGES IN HEIGHT OF CHOROIDAL MELANOMAS AFTER PLAQUE THERAPY [J].
ABRAMSON, DH ;
SERVODIDIO, CA ;
MCCORMICK, B ;
FASS, D ;
ZANG, E .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1990, 74 (06) :359-362
[2]   REGRESSION OF POSTERIOR UVEAL MALIGNANT MELANOMAS AFTER COBALT PLAQUE RADIOTHERAPY [J].
AUGSBURGER, JJ ;
MCNEARY, BT ;
VONBELOW, H ;
GAMEL, JW ;
SHIELDS, JA ;
BRADY, LW ;
MARKOE, AM ;
DAY, JL .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1986, 224 (05) :397-400
[3]   Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma:: 5 years' experience [J].
Bartlema, YM ;
Oosterhuis, JA ;
Journée-de Korver, JG ;
Tjho-Heslinga, RE ;
Keunen, JEE .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (11) :1370-1373
[4]  
CHAR DH, 1983, OPHTHALMOLOGY, V90, P1219
[5]   Regression Patterns of Iris Melanoma after Palladium-103 (103Pd) Plaque Brachytherapy [J].
Chaugule, Sonal S. ;
Finger, Paul T. .
OPHTHALMOLOGY, 2017, 124 (07) :1023-1030
[6]   Dosimetry of 125I and 103Pd COMS eye plaques for intraocular tumors: Report of Task Group 129 by the AAPM and ABS [J].
Chiu-Tsao, Sou-Tung ;
Astrahan, Melvin A. ;
Finger, Paul T. ;
Followill, David S. ;
Meigooni, Ali S. ;
Melhus, Christopher S. ;
Mourtada, Firas ;
Napolitano, Mary E. ;
Nath, Ravinder ;
Rivard, Mark J. ;
Rogers, D. W. O. ;
Thomson, Rowan M. .
MEDICAL PHYSICS, 2012, 39 (10) :6161-6184
[7]  
CRUESS AF, 1984, OPHTHALMOLOGY, V91, P1716
[8]   Regression Rate of Posterior Uveal Melanomas Following Iodine-125 Plaque Radiotherapy [J].
Demirci, Hakan ;
Saponara, Fiorella ;
Khan, Adam ;
Niziol, Leslie M. ;
Lee, Choonik ;
Hayman, James A. ;
Comer, Grant ;
Musch, David C. .
MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2015, 22 (01) :103-107
[9]   Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma [J].
Egger, E ;
Schalenbourg, A ;
Zografos, L ;
Bercher, L ;
Boehringer, T ;
Chamot, L ;
Goitein, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (01) :138-147
[10]   Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (avastin) [J].
Finger, Paul T. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04) :974-977